HMOX1 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, in addition to HO-1 expression by leukemic and MDS cells, CML, AML, and ALL leukemic stem cells express this protein as well, making it a potential target for eliminating minimal residual disease (MRD).